NCT01669915View on ClinicalTrials.gov

A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline

NACompletedINTERVENTIONAL
Enrollment

3,424

Participants

Timeline

Start Date

September 14, 2011

Primary Completion Date

June 8, 2016

Study Completion Date

December 31, 2021

Conditions
Cognitive Decline
Interventions
DIETARY_SUPPLEMENT

vitamin D3

Vitamin D3 (cholecalciferol), 2000 IU per day

DRUG

omega-3 fatty acids (fish oil)

Omacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\]).

DIETARY_SUPPLEMENT

Vitamin D3 placebo

Vitamin D placebo

DIETARY_SUPPLEMENT

Fish oil placebo

Fish oil placebo

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT01669915 - A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline | Biotech Hunter | Biotech Hunter